Author:
Matsuda Takaaki,Osaki Yoshinori,Maruo Kazushi,Matsuda Erika,Suzuki Yasuhiro,Suzuki Hiroaki,Mathis Bryan J.,Shimano Hitoshi,Mizutani Masakazu
Abstract
Abstract
Background
To evaluate the seasonal variability of urinary albumin to creatinine ratio (UACR) and eGFR and these effects on three-year eGFR slope in persons with type 2 diabetes (T2D).
Methods
A total of 1135 persons with T2D were analyzed in this single-center, retrospective cohort study in Japan. The standard deviation (SD) of UACR (SD [UACR]) and SD of eGFR (SD [eGFR]) were calculated for each person’s 10-point data during the three years, and a multiple linear regression analysis was performed to evaluate associations with eGFR slope. A sensitivity analysis was performed in a group with no medication changes (n = 801).
Results
UACR exhibited seasonal variability, being higher in winter and lower in spring, early summer, and autumn especially in the UACR ≥ 30 mg/g subgroup, while eGFR showed no seasonal variability. The eGFR slope was significantly associated with SD (eGFR) (regression coefficient -0.170 [95% CI -0.189–-0.151]) and SD (UACR) (0.000 [-0.001–0.000]). SGLT-2 inhibitors, baseline eGFR, and baseline systolic blood pressure (SBP) were also significantly associated. These associated factors, except baseline SBP, were still significant in the sensitivity analysis.
Conclusions
The UACR showed clear seasonal variability. Moreover, SD (UACR) and SD (eGFR) were independently associated with a three-year eGFR slope in persons with T2D.
Trial registration
This study was not registered for clinical trial registration because it was a retrospective observational study.
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Cheng H-T, Xu X, Lim PS, Hung K-Y. worldwide epidemiology of diabetes-related end-stage renal disease, 2000–2015. Diabetes Care. 2020;44(1):89–97.
2. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2020;98(4s):S1-s115.
3. Chronic Kidney Disease and Risk Management. Standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S175-s184.
4. Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, et al. Japanese clinical practice guideline for diabetes 2019. Diabetol Int. 2020;11(3):165–223.
5. Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort RT. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol. 2008;168(8):897–905.